Transition to newer clot-busting drug improves patient outcomes, lowers cost in treating ischemic stroke
A newer-generation stroke drug is outperforming the standard clot buster. A neurologist explains how tenecteplase saves both time and money when it comes to treating ischemic stroke.
from Latest Science News -- ScienceDaily https://ift.tt/C3Pn69V
from Latest Science News -- ScienceDaily https://ift.tt/C3Pn69V
Comments
Post a Comment